We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$147M
AUM Growth
+$1.82M
Cap. Flow
+$9.13M
Cap. Flow %
6.21%
Top 10 Hldgs %
77.72%
Holding
45
New
3
Increased
5
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
OCS icon
Oculis Holding
OCS
+$5.45M
2
GTLB icon
GitLab
GTLB
+$1.32M
3
MELI icon
Mercado Libre
MELI
+$1.03M
4
MRUS
Merus
MRUS
+$997K
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$172K

Top Sells

Rank Stock Value
1
JBIO
Jade Biosciences
JBIO
+$63K
2
SYBX
Synlogic
SYBX
+$52.2K
3
EAR
Eargo, Inc. Common Stock
EAR
+$8

Sector Composition

Rank Sector Weight
1 Healthcare 98.32%
2 Technology 0.86%
3 Consumer Discretionary 0.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EAR
26
DELISTED
Eargo, Inc. Common Stock
EAR
$692K 0.47%
147,904
-1
-0% -$8
KYNB
27
Kyntra Bio
KYNB
$29.4M
$636K 0.43%
1,364
– –
DBVT
28
DBV Technologies
DBVT
$847M
$627K 0.43%
37,095
– –
KALV
29
DELISTED
KalVista Pharmaceuticals
KALV
$619K 0.42%
78,720
– –
RYTM icon
30
Rhythm Pharmaceuticals
RYTM
$7.96B
$580K 0.39%
32,520
– –
TVTX icon
31
Travere Therapeutics
TVTX
$5.78B
$576K 0.39%
25,606
– –
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$5.03B
$564K 0.38%
29,984
– –
ARGX icon
33
argenx
ARGX
$54.1B
$533K 0.36%
1,430
+320
+29% +$118K
ASND icon
34
Ascendis Pharma A/S
ASND
$16.8B
$447K 0.3%
4,168
– –
MDGL icon
35
Madrigal Pharmaceuticals
MDGL
$11.8B
$286K 0.19%
1,182
– –
AFMD
36
DELISTED
Affimed
AFMD
$278K 0.19%
37,247
– –
ALXO icon
37
ALX Oncology
ALXO
$290M
$190K 0.13%
41,950
– –
BCRX icon
38
BioCryst Pharmaceuticals
BCRX
$2.4B
$149K 0.1%
+17,847
New +$172K
STSA
39
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$124K 0.08%
177,900
– –
KOD icon
40
Kodiak Sciences
KOD
$2.84B
$122K 0.08%
19,622
– –
NRIX icon
41
Nurix Therapeutics
NRIX
$2.65B
$102K 0.07%
11,500
– –
ABCL icon
42
AbCellera Biologics
ABCL
$2.12B
$94.4K 0.06%
12,521
– –
CERS icon
43
Cerus
CERS
$474M
$42.1K 0.03%
14,172
– –
NVTA
44
DELISTED
Invitae Corporation
NVTA
$15.3K 0.01%
11,337
– –
SYBX
45
DELISTED
Synlogic
SYBX
– –
-4,576
Closed -$52.2K
1
2

Similar funds

MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
MW
Merited Wealth North Bay Village, Florida $121M AUM

Nan Fung Group Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, Nan Fung Group Holdings held 45 positions worth $147M, up 1.3% from $145M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Nan Fung Group Holdings deployed $9.13M of net new capital in Q1 2023, opening 3 new positions and adding to 5 existing holdings. Its largest new stake was Oculis Holding: 651,100 shares worth $4.84M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 100% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Jade Biosciences, an estimated $63K trimmed.

  • Nan Fung Group Holdings's largest Q1 2023 buy was Oculis Holding: 651,100 shares worth $4.84M.
  • Nan Fung Group Holdings added most to GitLab in Q1 2023, an estimated $1.32M increase.
  • Nan Fung Group Holdings's biggest Q1 2023 reduction was Jade Biosciences, cutting an estimated $63K.
  • Nan Fung Group Holdings fully exited Synlogic in Q1 2023, selling an estimated $52.2K.
  • Nan Fung Group Holdings's ten largest holdings make up 78% of its $147M portfolio in Q1 2023.
  • Nan Fung Group Holdings opened 3 new positions and closed 1 in Q1 2023.
  • Nan Fung Group Holdings's portfolio value rose 1.3% quarter-over-quarter to $147M.

Based on Nan Fung Group Holdings's 13F filing for Q1 2023, filed 12 May 2023.